{"id":179232,"date":"2026-02-02T23:41:25","date_gmt":"2026-02-03T04:41:25","guid":{"rendered":"https:\/\/alphastreet.com\/india\/?p=179232"},"modified":"2026-02-02T23:41:25","modified_gmt":"2026-02-03T04:41:25","slug":"gpt-healthcare-posts-higher-nine-month-revenue-but-lower-margins-in-q3-fy26","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/gpt-healthcare-posts-higher-nine-month-revenue-but-lower-margins-in-q3-fy26\/","title":{"rendered":"GPT Healthcare posts higher nine-month revenue but lower margins in Q3 FY26"},"content":{"rendered":"\n

GPT Healthcare Ltd (BSE: 544131 \/ NSE: GPTHEALTH)<\/strong> reported higher revenue but lower profitability in the quarter ended December 31, 2025, reflecting rising costs and a still-ramping Raipur facility, while nine-month revenue grew at a double-digit rate on the back of higher patient volumes and improved ARPOB.<\/p>\n\n\n\n

For Q3 FY26, total revenue rose 16.8% year-on-year to \u20b9121.6 crore, but profit after tax declined 23.5% to \u20b99.4 crore. For the nine months ended December 2025, revenue increased 12.1% to \u20b9350.5 crore, while PAT fell 25.3% to \u20b927.6 crore.<\/p>\n\n\n\n

Business overview<\/strong><\/h2>\n\n\n\n

GPT Healthcare operates the ILS Hospitals<\/strong> brand, a neighbourhood tertiary-care hospital platform in Eastern India. As of December 2025, the company operated five multi-specialty hospitals at Salt Lake, Agartala, Dum Dum, Howrah and Raipur, with a combined capacity of 719 beds.<\/p>\n\n\n\n

The company follows a proximity-based, capital-efficient model focused on dense residential catchments, with clinical capabilities across oncology, cardiology, renal transplants and robotic surgery.<\/p>\n\n\n\n

Financial performance \u2014 Q3 FY26<\/strong><\/h2>\n\n\n\n

Total revenue in Q3 FY26 was \u20b9121.6 crore, compared with \u20b9104.1 crore in Q3 FY25 and \u20b9120.2 crore in Q2 FY26. EBITDA declined 4.4% year-on-year to \u20b922.2 crore, with EBITDA margin contracting to 18.2% from 22.2%.<\/p>\n\n\n\n

Profit before tax fell 27.6% to \u20b912.8 crore, while PAT declined to \u20b99.4 crore from \u20b912.1 crore a year earlier. Employee benefits and other expenses rose, contributing to margin compression.<\/p>\n\n\n\n

Nine-month performance (9M FY26)<\/strong><\/h2>\n\n\n\n

For 9M FY26, revenue increased to \u20b9350.5 crore from \u20b9312.6 crore in 9M FY25. EBITDA fell 6.4% to \u20b965.1 crore, with margin easing to 18.6%. PAT declined to \u20b927.6 crore from \u20b937.0 crore. Average Revenue Per Occupied Bed (ARPOB) for 9M FY26 rose 6% year-on-year to \u20b938,797.<\/p>\n\n\n\n

Operating metrics<\/strong><\/h2>\n\n\n\n

Overall network occupancy in 9M FY26 was 45%. Excluding the newly commissioned Raipur hospital, occupancy improved marginally to 55% from 54% a year earlier.<\/p>\n\n\n\n

Total patient volumes for 9M FY26 were broadly stable, with 25,608 inpatients and 1,59,894 outpatients. Average length of stay declined to 3.48 days.<\/p>\n\n\n\n

Hospital-wise performance showed higher ARPOB across Salt Lake, Dum Dum and Raipur, while occupancy remained below mature-asset levels at Raipur as the facility continued to scale.<\/p>\n\n\n\n

Key developments<\/strong><\/h2>\n\n\n\n

GPT Healthcare commissioned CTVS (Cardiothoracic and Vascular Surgery) at ILS Dum Dum, enabling end-to-end cardiac care under one roof. The Raipur facility, which began operations in May 2025, continued to ramp up, with occupancy rising sequentially.<\/p>\n\n\n\n

The company progressed its 150-bed Jamshedpur project under a MoU, targeting commissioning by end-FY27, with land and building to be funded by developers under fixed rental arrangements.<\/p>\n\n\n\n

Capital and expansion<\/strong><\/h2>\n\n\n\n

Management outlined plans to scale to a 1,000-bed network by 2027 through expansion in Tier-I and Tier-II cities in Eastern India, with a focus on asset-light models and disciplined capital allocation.<\/p>\n\n\n\n

Risks and constraints<\/strong><\/h2>\n\n\n\n

Disclosures indicate that profitability remains sensitive to occupancy levels, cost inflation in manpower and consumables, the pace of ramp-up at new facilities, competitive intensity in key catchments, and execution risks in expansion projects.<\/p>\n\n\n\n

Outlook and commentary<\/strong><\/h2>\n\n\n\n

Management said higher ARPOB, improved specialty mix and better clinical throughput supported revenue growth, while near-term margins were affected by investments in newer facilities and higher operating costs.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n","protected":false},"excerpt":{"rendered":"

GPT Healthcare Ltd (BSE: 544131 \/ NSE: GPTHEALTH) reported higher revenue but lower profitability in the quarter ended December 31, 2025, reflecting rising costs and a still-ramping Raipur facility, while nine-month revenue grew at a double-digit rate on the back of higher patient volumes and improved ARPOB. For Q3 FY26, total revenue rose 16.8% year-on-year […]<\/p>\n","protected":false},"author":2390,"featured_media":125416,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[392,1941,5747,5],"tags":[15566,15569,14580,15560,15570,15561,15562,15565,15568,15563,15564,15571,15567,14559,15572],"class_list":["post-179232","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-earnings","category-stock-analysis","category-healthcare-stocks","category-latest","tag-arpob","tag-bse-544131","tag-corporate-earnings-india","tag-gpt-healthcare","tag-gpt-healthcare-earnings","tag-gpt-healthcare-ltd","tag-gpt-healthcare-q3-fy26","tag-gpt-healthcare-results","tag-healthcare-sector-india","tag-hospital-industry-india","tag-hospital-occupancy","tag-ils-hospitals","tag-nse-gpthealth","tag-quarterly-results-india","tag-tertiary-care-hospitals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":174211,"url":"https:\/\/alphastreet.com\/india\/gpt-healthcare-ltd-gpthealth-q1-2026-earnings-call-transcript\/","url_meta":{"origin":179232,"position":0},"title":"GPT Healthcare Ltd (GPTHEALTH) Q1 2026 Earnings Call Transcript","author":"News desk","date":"January 22, 2026","format":false,"excerpt":"GPT Healthcare Ltd (NSE: GPTHEALTH) Q1 2026 Earnings Call dated Aug. 07, 2025 Corporate Participants: Unidentified Speaker Atul Tantia \u2014 Group Chief Financial Officer Analysts: Unidentified Participant Naman Bansal \u2014 Analyst Presentation: operator Ladies and gentlemen, good day and welcome to GPT Healthcare Limited Q1FY26 earnings conference call. As a\u2026","rel":"","context":"In "Earnings Call Transcripts"","block_context":{"text":"Earnings Call Transcripts","link":"https:\/\/alphastreet.com\/india\/category\/transcripts\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":180003,"url":"https:\/\/alphastreet.com\/india\/jeena-sikho-lifecare-limited-reports-sharp-q3-fy26-growth-as-revenue-and-profit-surge\/","url_meta":{"origin":179232,"position":1},"title":"Jeena Sikho Lifecare Limited reports sharp Q3 FY26 growth as revenue and profit surge","author":"Staff Correspondent","date":"February 9, 2026","format":false,"excerpt":"Jeena Sikho Lifecare Limited (NSE: JSLL, BSE: 544476) reported strong financial and operating performance for the quarter ended December 31, 2025, driven by rapid expansion across its Ayurveda healthcare services and products businesses, according to the company\u2019s Q3 FY26 investor presentation. Financial performance Revenue from operations rose to \u20b9221.66 crore\u2026","rel":"","context":"In "LATEST"","block_context":{"text":"LATEST","link":"https:\/\/alphastreet.com\/india\/category\/latest\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/10\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/10\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/10\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":180874,"url":"https:\/\/alphastreet.com\/india\/fortis-healthcare-revenue-rises-17-5-in-q3-while-exceptional-costs-weigh-on-profit\/","url_meta":{"origin":179232,"position":2},"title":"Fortis Healthcare Revenue Rises 17.5% in Q3 While Exceptional Costs Weigh on Profit","author":"Staff Correspondent","date":"February 16, 2026","format":false,"excerpt":"Fortis Healthcare Ltd (FORTIS) shares ended lower on the National Stock Exchange and Bombay Stock Exchange on Monday, February 16, 2026, following the disclosure of its third-quarter financial results. The stock closed at \u20b9916.75 on the NSE, representing an intraday decline of 1.23%. Trading volume for the session reached approximately\u2026","rel":"","context":"In "LATEST"","block_context":{"text":"LATEST","link":"https:\/\/alphastreet.com\/india\/category\/latest\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":179566,"url":"https:\/\/alphastreet.com\/india\/metropolis-healthcare-posts-higher-revenue-and-margins-in-q3-fy26-on-volume-growth-and-mix-improvement\/","url_meta":{"origin":179232,"position":3},"title":"Metropolis Healthcare posts higher revenue and margins in Q3 FY26 on volume growth and mix improvement","author":"Staff Correspondent","date":"February 4, 2026","format":false,"excerpt":"Metropolis Healthcare Limited (BSE: 542650 \/ NSE: METROPOLIS) reported higher revenue and profitability in the quarter ended December 31, 2025, supported by rising patient and test volumes, stronger B2C and B2B traction, and an improved mix toward specialty and TruHealth offerings. For Q3 FY26 (MHL Group), revenue increased 26% year-on-year\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":178979,"url":"https:\/\/alphastreet.com\/india\/aster-dm-healthcare-q3-fy26-results-revenue-rises-13-yoy-as-margins-improve-sequentially-profitability-moderated-by-exceptional-costs\/","url_meta":{"origin":179232,"position":4},"title":"Aster DM Healthcare Q3 FY26 Results: Revenue Rises 13% YoY as Margins Improve Sequentially; Profitability Moderated by Exceptional Costs","author":"Staff Correspondent","date":"February 2, 2026","format":false,"excerpt":"Aster DM Healthcare Limited (NSE: ASTERDM) reported consolidated revenue from operations of \u20b91,186 crore for the quarter ended December 31, 2025, representing a 13% year-on-year increase. Growth was led by higher patient volumes and improved realizations across core hospital clusters. Operating EBITDA rose 11% year-on-year to \u20b9224 crore. Operating EBITDA\u2026","rel":"","context":"In "Analysis"","block_context":{"text":"Analysis","link":"https:\/\/alphastreet.com\/india\/category\/stock-analysis\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":177088,"url":"https:\/\/alphastreet.com\/india\/cyient-dlm-ltd-shares-fall-after-q3-fy26-results\/","url_meta":{"origin":179232,"position":5},"title":"Cyient DLM Ltd Shares Fall After Q3 FY26 Results","author":"Staff Correspondent","date":"January 20, 2026","format":false,"excerpt":"Cyient DLM Ltd (NSE: CYIENTDLM, BSE: 543933) shares closed at approximately \u20b9366.3 on Wednesday, down about 2.6% from the previous session, after the company reported its third-quarter financial results for fiscal year 2026. Market Capitalization At the latest close, Cyient DLM\u2019s market capitalization stood at around \u20b92,900 crore. Latest Quarterly\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/179232","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/2390"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=179232"}],"version-history":[{"count":1,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/179232\/revisions"}],"predecessor-version":[{"id":179235,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/179232\/revisions\/179235"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/125416"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=179232"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=179232"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=179232"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}